NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/PSM/Contraceptive Methods — Epidemiology
    Contraceptive Methods — Epidemiology
    medium
    users PSM

    A 28-year-old Indian woman seeks contraception. She has a history of migraine with aura and irregular menstrual cycles. Which feature best distinguishes the suitability of progestin-only pills (POP) from combined oral contraceptives (COC) in her case?

    A. POP requires daily intake at the same time each day with a narrower window (3-hour window), whereas COC has a 12-hour window
    B. POP has a lower failure rate (0.3 per 100 woman-years) than COC (9 per 100 woman-years) in typical use
    C. POP causes amenorrhea in 80% of users, whereas COC maintains regular menstrual cycles in all users
    D. POP does not contain estrogen and is safe in women with migraine with aura, whereas COC carries a thrombotic risk in this population

    Explanation

    ## Contraceptive Choice in Migraine with Aura: POP vs COC ### Clinical Context: Migraine with Aura **Key Point:** Migraine with aura is a **relative contraindication (Category 3) to estrogen-containing contraceptives** due to increased risk of ischemic stroke. This is a critical distinction in contraceptive counselling. ### Why Estrogen Is Problematic in Migraine with Aura 1. **Migraine with aura** involves transient neurological symptoms (visual scotoma, sensory disturbance) preceding headache 2. Aura is thought to reflect cortical spreading depression and transient cerebral vasoconstriction 3. **Estrogen** increases thrombotic risk and may potentiate vasospasm 4. Combined effect: **2–4-fold increased stroke risk** in women using estrogen-containing contraceptives with migraine with aura 5. WHO MEC Category 3 (risks outweigh benefits; use with caution) or Category 4 (unacceptable risk) depending on severity ### POP (Progestin-Only Pill) — Safe Alternative - Contains **no estrogen** - Mechanism: primarily cervical mucus thickening + occasional ovulation suppression - **No increased thrombotic risk** - **Safe in migraine with aura** (WHO MEC Category 1–2) - Suitable for this patient ### COC (Combined Oral Contraceptive) — Contraindicated - Contains both estrogen and progestin - Estrogen component carries thrombotic risk - **Contraindicated in migraine with aura** (WHO MEC Category 3–4) - Increases stroke risk in this population ### Comparison Table | Feature | POP | COC | | --- | --- | --- | | **Estrogen content** | None | Yes (20–35 µg EE typical) | | **Thrombotic risk** | No increase | Increased (especially with migraine + aura) | | **WHO MEC in migraine with aura** | Category 1–2 (safe) | Category 3–4 (contraindicated) | | **Stroke risk** | No additional risk | 2–4× increased | | **Mechanism** | Cervical mucus + ovulation suppression (variable) | Ovulation suppression + cervical mucus | | **Typical-use failure rate** | 9 per 100 WY | 9 per 100 WY | **High-Yield:** The **absence of estrogen** in POP is the single best discriminator for safety in migraine with aura. This is a high-yield fact for NEET PG — migraine with aura is a classic scenario testing knowledge of estrogen-related contraindications. **Clinical Pearl:** Always ask about **migraine with aura** (not just migraine) when counselling on COC. Migraine without aura is Category 1–2 (safe); migraine with aura is Category 3–4 (contraindicated). **Mnemonic:** **"ACHES"** — warning signs of COC complications: - **A**bdominal pain (VTE) - **C**hest pain (PE, MI) - **H**eadache (stroke, especially with aura) - **E**ye problems (stroke) - **S**evere leg pain (DVT) Migraine with aura falls under the "H" category — headache as a warning sign. [cite:Park 26e Ch 8; WHO Medical Eligibility Criteria for Contraceptive Use 5e]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More PSM Questions